{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:00:11Z","timestamp":1763704811449},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00417-012-2207-1","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T21:12:51Z","timestamp":1354223571000},"page":"515-520","source":"Crossref","is-referenced-by-count":4,"title":["Effects of orally administered moxaverine on ocular blood flow in healthy subjects"],"prefix":"10.1007","volume":"251","author":[{"given":"Doreen","family":"Schmidl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthold","family":"Pemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lasta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Boltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semira","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Palkovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Prager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopold","family":"Schmetterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Garhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"key":"2207_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/IIO.0b013e31821e51f9","volume":"51","author":"DS Grover","year":"2011","unstructured":"Grover DS, Budenz DL (2011) Ocular perfusion pressure and glaucoma. Int Ophthalmol Clin 51:19\u201325","journal-title":"Int Ophthalmol Clin"},{"key":"2207_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3129\/i08-049","volume":"43","author":"B Pemp","year":"2008","unstructured":"Pemp B, Schmetterer L (2008) Ocular blood flow in diabetes and age-related macular degeneration. Can J Ophthalmol 43:295\u2013301","journal-title":"Can J Ophthalmol"},{"key":"2207_CR3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","volume":"21","author":"J Flammer","year":"2002","unstructured":"Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefansson E (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21:359\u2013393","journal-title":"Prog Retin Eye Res"},{"key":"2207_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/IIO.0b013e3181a8df6c","volume":"49","author":"DW DelMonte","year":"2009","unstructured":"DelMonte DW, Bhatti MT (2009) Ischemic optic neuropathy. Int Ophthalmol Clin 49:35\u201362","journal-title":"Int Ophthalmol Clin"},{"key":"2207_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exer.2010.09.002","volume":"93","author":"D Schmidl","year":"2011","unstructured":"Schmidl D, Garhofer G, Schmetterer L (2011) The complex interaction between ocular perfusion pressure and ocular blood flow \u2014 Relevance for glaucoma. Exp Eye Res 93:141\u2013155","journal-title":"Exp Eye Res"},{"key":"2207_CR6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.44.6.603","volume":"44","author":"EM Kohner","year":"1995","unstructured":"Kohner EM, Patel V, Rassam SM (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44:603\u2013607","journal-title":"Diabetes"},{"key":"2207_CR7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1034\/j.1600-0420.2002.800503.x","volume":"80","author":"TA Ciulla","year":"2002","unstructured":"Ciulla TA, Harris A, Latkany P, Piper HC, Arend O, Garzozi H, Martin B (2002) Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand 80:468\u2013477","journal-title":"Acta Ophthalmol Scand"},{"key":"2207_CR8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preteyeres.2010.09.002","volume":"30","author":"M Araie","year":"2011","unstructured":"Araie M, Mayama C (2011) Use of calcium channel blockers for glaucoma. Prog Retin Eye Res 30:54\u201371","journal-title":"Prog Retin Eye Res"},{"key":"2207_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000310566","volume":"209","author":"AZ Gaspar","year":"1995","unstructured":"Gaspar AZ, Gasser P, Flammer J (1995) The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 209:11\u201313","journal-title":"Ophthalmologica"},{"key":"2207_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/112067211002000118","volume":"20","author":"B Aydin","year":"2010","unstructured":"Aydin B, Onol M, Hondur A, Kaya MG, Ozdemir H, Cengel A, Hasanreisoglu B (2010) The effect of oral magnesium therapy on visual field and ocular blood flow in normotensive glaucoma. Eur J Ophthalmol 20:131\u2013135","journal-title":"Eur J Ophthalmol"},{"key":"2207_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2125.1997.t01-1-00598.x","volume":"44","author":"B Matulla","year":"1997","unstructured":"Matulla B, Streit G, Pieh S, Findl O, Entlicher J, Graselli U, Eichler HG, Wolzt M, Schmetterer L (1997) Effects of losartan on cerebral and ocular circulation in healthy subjects. Br J Clin Pharmacol 44:369\u2013375","journal-title":"Br J Clin Pharmacol"},{"key":"2207_CR12","first-page":"217","volume":"1","author":"K Hirooka","year":"2007","unstructured":"Hirooka K, Shiraga F (2007) Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma. Clin Ophthalmol 1:217\u2013223","journal-title":"Clin Ophthalmol"},{"key":"2207_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/jop.1999.15.233","volume":"15","author":"HS Chung","year":"1999","unstructured":"Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R (1999) Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther 15:233\u2013240","journal-title":"J Ocul Pharmacol Ther"},{"key":"2207_CR14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.0306-5251.2001.01432.x","volume":"52","author":"G Rainer","year":"2001","unstructured":"Rainer G, Kiss B, Dallinger S, Findl O, Georgopoulos M, Vass C, Menapace R, Polak K, Eichler HG, Wolzt M, Schmetterer L (2001) A double masked placebo controlled study on the effect of nifedipine on optic nerve blood flow and visual field function in patients with open angle glaucoma. Br J Clin Pharmacol 52:210\u2013212","journal-title":"Br J Clin Pharmacol"},{"key":"2207_CR15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1755-3768.2008.01338.x","volume":"87","author":"H Resch","year":"2009","unstructured":"Resch H, Weigert G, Karl K, Pemp B, Garhofer G, Schmetterer L (2009) Effect of systemic moxaverine on ocular blood flow in humans. Acta Ophthalmol 87:731\u2013735","journal-title":"Acta Ophthalmol"},{"key":"2207_CR16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1755-3768.2010.01878.x","volume":"90","author":"B Pemp","year":"2012","unstructured":"Pemp B, Garhofer G, Lasta M, Schmidl D, Wolzt M, Schmetterer L (2012) The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects. Acta Ophthalmologica 90:139\u2013145","journal-title":"Acta Ophthalmologica"},{"key":"2207_CR17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bjo.2003.028480","volume":"88","author":"E Polska","year":"2004","unstructured":"Polska E, Polak K, Luksch A, Fuchsjager-Mayrl G, Petternel V, Findl O, Schmetterer L (2004) Twelve hour reproducibility of choroidal blood flow parameters in healthy subjects. Br J Ophthalmol 88:533\u2013537","journal-title":"Br J Ophthalmol"},{"key":"2207_CR18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1755-3768.2008.01388.x","volume":"87","author":"A Luksch","year":"2009","unstructured":"Luksch A, Lasta M, Polak K, Fuchsjager-Mayrl G, Polska E, Garhofer G, Schmetterer L (2009) Twelve-hour reproducibility of retinal and optic nerve blood flow parameters in healthy individuals. Acta Ophthalmol 87:875\u2013880","journal-title":"Acta Ophthalmol"},{"key":"2207_CR19","unstructured":"Ursapharm (1987) Pharmakokinetik von Moxaverin per os unter Mehrfachdosisbedingungen. Iphar Study 87\/253"},{"key":"2207_CR20","unstructured":"Ursapharm (2010) Kollateral forte 150\u00a0mg dragees: prescribing information. Edition 3\/2010"},{"key":"2207_CR21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1991.01080040095036","volume":"109","author":"WE Lieb","year":"1991","unstructured":"Lieb WE, Cohen SM, Merton DA, Shields JA, Mitchell DG, Goldberg BB (1991) Color Doppler imaging of the eye and orbit. Technique and normal vascular anatomy. Arch Ophthalmol 109:527\u2013531","journal-title":"Arch Ophthalmol"},{"key":"2207_CR22","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1111\/j.1755-3768.2011.02178.x","volume":"89","author":"I Stalmans","year":"2011","unstructured":"Stalmans I, Vandewalle E, Anderson DR, Costa VP, Frenkel RE, Garhofer G, Grunwald J, Gugleta K, Harris A, Hudson C, Januleviciene I, Kagemann L, Kergoat H, Lovasik JV, Lanzl I, Martinez A, Nguyen QD, Plange N, Reitsamer HA, Sehi M, Siesky B, Zeitz O, Orgul S, Schmetterer L (2011) Use of colour Doppler imaging in ocular blood flow research. Acta Ophthalmol 89:e609\u2013630","journal-title":"Acta Ophthalmol"},{"key":"2207_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0014-4835(92)90123-A","volume":"55","author":"CE Riva","year":"1992","unstructured":"Riva CE, Harino S, Petrig BL, Shonat RD (1992) Laser Doppler flowmetry in the optic nerve. Exp Eye Res 55:499\u2013506","journal-title":"Exp Eye Res"},{"key":"2207_CR24","first-page":"4273","volume":"35","author":"CE Riva","year":"1994","unstructured":"Riva CE, Cranstoun SD, Grunwald JE, Petrig BL (1994) Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci 35:4273\u20134281","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2207_CR25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1755-3768.2009.01621.x","volume":"88","author":"CE Riva","year":"2010","unstructured":"Riva CE, Geiser M, Petrig BL (2010) Ocular blood flow assessment using continuous laser Doppler flowmetry. Acta Ophthalmol 88:622\u2013629","journal-title":"Acta Ophthalmol"},{"key":"2207_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0002-9394(14)70581-1","volume":"121","author":"L Schmetterer","year":"1996","unstructured":"Schmetterer L, Kemmler D, Breiteneder H, Alschinger C, Koppensteiner R, Lexer F, Fercher AF, Eichler HG, Wolzt M (1996) A randomized, placebo-controlled, double-blind crossover study of the effect of pentoxifylline on ocular fundus pulsations. Am J Ophthalmol 121:169\u2013176","journal-title":"Am J Ophthalmol"},{"key":"2207_CR27","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/archopht.1993.01090120069024","volume":"111","author":"PL Sonkin","year":"1993","unstructured":"Sonkin PL, Kelly LW, Sinclair SH, Hatchell DL (1993) Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes. Arch Ophthalmol 111:1647\u20131652","journal-title":"Arch Ophthalmol"},{"key":"2207_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0002-9394(14)73647-5","volume":"115","author":"PL Sonkin","year":"1993","unstructured":"Sonkin PL, Sinclair SH, Hatchell DL (1993) The effect of pentoxifylline on retinal capillary blood flow velocity and whole blood viscosity. Am J Ophthalmol 115:775\u2013780","journal-title":"Am J Ophthalmol"},{"key":"2207_CR29","first-page":"27","volume":"116","author":"A Kruger","year":"1998","unstructured":"Kruger A, Matulla B, Wolzt M, Pieh S, Strenn K, Findl O, Eichler HG, Schmetterer L (1998) Short-term oral pentoxifylline use increases choroidal blood flow in patients with age-related macular degeneration. Arch Ophthalmol 116:27\u201330","journal-title":"Arch Ophthalmol"},{"key":"2207_CR30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/A:1014410932321","volume":"23","author":"G Paris","year":"2001","unstructured":"Paris G, Sponsel WE, Sandoval SS, Elliott WR, Trigo Y, Sanford DK, Harrison JM (2001) Sildenafil increases ocular perfusion. Int Ophthalmol 23:355\u2013358","journal-title":"Int Ophthalmol"},{"key":"2207_CR31","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1167\/iovs.03-0177","volume":"44","author":"K Polak","year":"2003","unstructured":"Polak K, Wimpissinger B, Berisha F, Georgopoulos M, Schmetterer L (2003) Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects. Invest Ophthalmol Vis Sci 44:4872\u20134876","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2207_CR32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/eye.2001.163","volume":"15","author":"SO Dundar","year":"2001","unstructured":"Dundar SO, Dundar M, Kocak I, Dayanir Y, Ozkan SB (2001) Effect of sildenafil on ocular haemodynamics. Eye (Lond) 15:507\u2013510","journal-title":"Eye (Lond)"},{"key":"2207_CR33","first-page":"1806","volume":"38","author":"R Mannhold","year":"1988","unstructured":"Mannhold R (1988) Inhibition of calmodulin dependent c-AMP-phosphodiesterase by moxaverine and papaverine. Arzneimittelforschung 38:1806\u20131808","journal-title":"Arzneimittelforschung"},{"key":"2207_CR34","first-page":"288","volume":"290","author":"G Berg","year":"1987","unstructured":"Berg G, Andersson RG, Ryden G (1987) Effects of different phosphodiesterase-inhibiting drugs on human pregnant myometrium: an in vitro study. Arch Int Pharmacodyn Ther 290:288\u2013292","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"2207_CR35","first-page":"710","volume":"38","author":"H Schmid-Schonbein","year":"1988","unstructured":"Schmid-Schonbein H, Schroder S, Grebe R, Artmann G, Eschweiler H, Teitel P (1988) Influence of moxaverine hydrochloride on membrane curvature and microsieve filterability of red cells after exposure to hyperosmolarity and lactacidosis. Arzneimittelforschung 38:710\u2013716","journal-title":"Arzneimittelforschung"},{"key":"2207_CR36","first-page":"1348","volume":"116","author":"G Feine-Haake","year":"1977","unstructured":"Feine-Haake G, Haase W, Weschenfelder R (1977) Treatment of cerebrovascular disorders using Kollateral-P degrees. Open long-term study in a home for the aged. Ther Ggw 116:1348\u20131358","journal-title":"Ther Ggw"},{"key":"2207_CR37","first-page":"1131","volume":"117","author":"G Feine-Haake","year":"1975","unstructured":"Feine-Haake G, Neiss A, Weinert W (1975) The treatment of cerebrovascular insufficiency. Their evaluation in a double-blind study. MMW Munch Med Wochenschr 117:1131\u20131132","journal-title":"MMW Munch Med Wochenschr"},{"key":"2207_CR38","first-page":"1006","volume":"113","author":"H Nordeck","year":"1971","unstructured":"Nordeck H, Eichler K, Mulch R, Volker D (1971) Collateral dilatation therapy in coronary and peripheral arterial occlusive diseases. Experimental and clinical experiences with 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride (BEN). Munch Med Wochenschr 113:1006\u20131011","journal-title":"Munch Med Wochenschr"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-2207-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-012-2207-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-2207-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T03:49:19Z","timestamp":1562384959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-012-2207-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1007\/s00417-012-2207-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}